Chinese Journal of Drug Application and Monitoring - Digital Cluster of Scitech Periodicals

Home>Journals>Chinese Journal of Drug Application and Monitoring

Chinese Journal of Drug Application and Monitoring

ISTIC

ISSN：1672-8157

CN：11-5227/R

Frequency：Monthly

Website：none

Email：zhgywyyyjc@263.net

Postcode：100041

Articles3880

Citations20848

Funded1209

Impact Factor：1.529

Articles

2018 No.01

Total 17 articles

Correlation study between GPⅢa PLA2, PEAR1, PTGS1 gene polymorphisms and clinical antithrombotic efficacy of aspirinSHI Xiu-jin, HU Zhi-xu, PENG Wen-xing, LI Xiao, XU Xiao-yu, XU Xi-qiao, LIN Yang

1-4

Determination of arsenic metabolites in urine of acute promyelocytic leukemia patients treated with arsenic trioxide by HPLC-HG-AFSWANG Wen-jing, HU Shuang, GUO Mei-hua, GAO Chun-lu, HAI Xin

5-8,12

Study on the establishment and applicability of microbial limit test for two kinds of sulfur resorcinol lotionTIAN Huai-ping, LIN Zhi-yan, LI Chao, HU Yan-feng

9-12

Pharmaceutical care of one child patient with AIH-PSC overlap syndrome and ulcerative colitisZHU Hong, CHEN Zhe, WANG Tian-heng, ZHAO Qing-guo

13-17

Discussion on clinical application of amphotericin B for bladder irrigation via one patient with urinary tract infectionDENG Yu-fei, WANG Dong-xiao

17-20

Pharmaceutical care on a child patient with delay excretion of methotrexateTAO Xing-ru, CHEN Hai-yan

21-23,39

Summary analysis of myasthenia gravis induced/aggravated by quinolonesXIE Huan, CHEN Ying, WEI Feng

24-27

Analysis on 310 cases of serious adverse drug reaction and event associated with quinolones in military hospitalsHUANG Cui-li, GUO Dai-hong, ZHU Man, SU Chang, WU Xu, ZHAO Su-yu, MA Liang, ZHAO Peng-zhi, ZHAO Liang

28-31

Analysis and intervention measures on 216 cases of drug-induced liver injury in primary medical institutionsZHANG Lin-xiang, SHEN Ming, QIU Gang, ZHAO Ying-fei

32-35

Clinical analysis of 1946 cases of adverse drug reactions associated with chemotherapy in cancer patientsWANG Rui-qing, ZHANG Yan-hua, LIU Hong

36-39